TLDR
- Oracle stock has dropped 24% over nine consecutive losing days, its longest streak since December 2021.
- The stock is down 57% from its all-time closing high of $345.72 set on September 10, 2025.
- 84% of Wall Street analysts covering ORCL rate it a Buy, with an average price target of $254.84.
- Investor concern centers on Oracle’s heavy capital expenditure spending and a debt-to-equity ratio of 3.21.
- Vice Chairman Jeffrey Henley sold $63.7 million worth of stock on June 24 under a pre-arranged trading plan.
Oracle (ORCL) stock opened at $140.27 on Friday, continuing a slide that has rattled investors despite near-record levels of analyst optimism.
The stock has now fallen for nine straight trading days, losing 24% over that stretch. It’s the longest losing streak for ORCL since December 2021.
Zoom out further and the picture is worse. Since hitting a 2026 high of $248.15 on June 1, Oracle has fallen on 18 out of 22 trading days. From its all-time closing high of $345.72 on September 10, 2025, the stock is down 57%.
What makes this unusual is the backdrop. The broader software sector has been recovering. The iShares Expanded Tech-Software Sector ETF (IGV) is up more than 10% over the past five trading days. Oracle is moving in the opposite direction.
Analysts Still Bullish
Wall Street isn’t buying the selloff — literally. 84% of analysts covering ORCL rate it a Buy, according to FactSet. That’s the highest Buy percentage in roughly 20 years, except for a brief period in May 2011.
The average price target sits at $254.84, implying around 82% upside from Thursday’s close.
Mizuho analyst Siti Panigrahi has a $320 price target and calls Oracle one of the firm’s top picks, citing its AI stack across database, infrastructure, and applications. KeyBanc analysts, who carry a $300 target and an Overweight rating, said last month they are “increasingly comfortable” that operating expense growth will stay muted.
Piper Sandler raised its target to $225 with an Overweight rating. Bank of America moved its target to $240 with a Buy. The consensus across 38 analysts sits at a Moderate Buy with an average target of $268.27.
Capex and Debt Weigh on Sentiment
The concern for investors isn’t Oracle’s business performance — it actually beat Q4 earnings, posting $2.11 EPS against estimates of $1.96, on revenue of $19.18 billion, up 20.6% year-over-year.
The worry is what it’s spending to get there. Oracle is investing heavily in AI infrastructure, and Mizuho’s Panigrahi noted the company will likely need outside financing to fund that capex. He flagged “financing challenges” as a key risk.
The debt-to-equity ratio currently stands at 3.21, which is hard to ignore.
Oracle has also flagged AI data center profitability risks in regulatory filings, which has added to investor unease around whether the AI buildout will pay off on a timeline the market is comfortable with.
Vice Chairman Jeffrey Henley sold 400,000 ORCL shares on June 24 at an average of $159.16, totaling $63.7 million. The sale was executed under a pre-arranged Rule 10b5-1 plan and reduced his direct holding by 50%.
Oracle’s 52-week low stands at $134.57. With the stock at $140.27, that floor isn’t far away.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.







